ProfileGDS4459 / ENSG00000105198
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 27% 6% 10% 14% 11% 6% 9% 9% 9% 5% 11% 9% 11% 19% 12% 13% 13% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.6527
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.696
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.310
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.2314
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.5411
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.376
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.39
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.279
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.199
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 1025
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.711
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.169
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.4611
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.419
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.412
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.0813
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.0713